Previous close | 505.34 |
Open | 503.37 |
Bid | 492.62 x 100 |
Ask | 493.65 x 300 |
Day's range | 491.80 - 506.59 |
52-week range | 372.50 - 583.39 |
Volume | |
Avg. volume | 426,567 |
Market cap | 40.926B |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | 49.03 |
EPS (TTM) | 10.05 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 604.06 |
IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits by pet owners and a stronger dollar. Visits to veterinary clinics, after a COVID-driven boom, have been disrupted due to staffing shortages in the past few years. IDEXX lowered its full-year revenue forecast to between $3.9 billion and $3.97 billion from its previous estimate of $3.93 billion to $4.04 billion.
Comprehensive Analysis of IDEXX's First Quarter Financial Performance
WESTBROOK, Maine, May 01, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.